TrialJournal of diabetes investigation2018

Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.

Ikuro Matsuba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.